Through multivariable logistic regression, we selected seven gene promoter regions (ALX4, BMP3, NPTX2, RARB, SDC2, SEPT9, and VIM), which could distinguish early stage CRC patients from a colonoscopy verified CRC free control population. This evidence concerns the gene ALX4 and colorectal carcinoma.